ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/21/2026
Back to search
Official data from USPTO
XEROZINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/21/2026
Trademark type
Word
Nice classes
5
Filing date
07/05/2012
Registration date
06/10/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/06/2024
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/11/2013
First use in commerce
01/11/2013
Drawing code
4
Owner type
03
Owner location
South Plainfield, NJ, US
Examiner
KEATING, MICHAEL P
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Geri Gentle Corp.
Geri Gentle Corp.
Representatives
Neil M. Zipkin AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal barrier cream to prevent skin irritations sold directly to health care facilities
Publications
History of USPTO decisions and trademark events.
33 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/06/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/06/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/06/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/16/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/10/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/23/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/23/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/23/2020
E815
TEAS SECTION 8 & 15 RECEIVED
05/07/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/03/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/01/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/29/2014
IUAF
USE AMENDMENT FILED
04/10/2014
EISU
TEAS STATEMENT OF USE RECEIVED
04/10/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/19/2013
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/07/2013
OP.T
OPPOSITION TERMINATED NO. 999999
10/07/2013
OP.D
OPPOSITION DISMISSED NO. 999999
10/07/2013
PAPER RECEIVED
10/02/2013
OP.I
OPPOSITION INSTITUTED NO. 999999
04/03/2013
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/03/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2012
PUBO
PUBLISHED FOR OPPOSITION
12/04/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/14/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2012
DOCK
ASSIGNED TO EXAMINER
10/25/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2012
NWAP
NEW APPLICATION ENTERED
07/09/2012
Continuous trademark protection
Get notified about every new filing that threatens XEROZINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.